Skip to main content
SpringerLink
Log in

Renovascular Hypertension

  • Chapter
  • First Online:
Secondary Hypertension

  • 831 Accesses

Abstract

Renovascular hypertension (RVH) refers to secondary hypertension caused by renal parenchymal ischemia due to stenosis or complete occlusion of unilateral or bilateral renal artery entrances, trunks or their main branches. Renal artery stenosis is a kind of renal vascular disease caused by a variety of causes. It is the anatomical basis of renal vascular hypertension. Generally, renal artery stenosis has hemodynamic significance only when it is more than 50%. Renal vascular hypertension can be caused by more than 70%. Common diseases include atherosclerotic renal artery stenosis, Takayasu arteritis, and fibromuscular dysplasia. Next were congenital renal artery dysplasia, vasculitis, arterial embolism, renal aneurysm, pheochromocytoma, metastatic aneurysm, renal artery constriction, etc.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Peng M, Jiang XJ, Dong H, et al. Etiology of renal artery stenosis in 2047 patients: a single-center retrospective analysis during a 15-year period in China. J Hum Hypertens. 2016;30(2):124–8.

    Article  CAS  PubMed  Google Scholar 

  2. Drafting Group of Expert Consensus of the Branch of Vascular Diseases and Hypertension, China Association for the Promotion of International Medical and Health Care. Chinese expert consensus on diagnosis and treatment of renal artery stenosis. Chin J Circ. 2017;9:835–44.

    Google Scholar 

  3. Harvin HJ, Verma N, Nikolaidis P, et al. ACR appropriateness criteria(®) renovascular hypertension. J Am Coll Radiol. 2017;14(11S):S540–9.

    Article  PubMed  Google Scholar 

  4. Odudu A, Vassallo D, Kalra PA. From anatomy to function: diagnosis of atherosclerntic renal artery stenosis. Expert Rev Cardiovasc Ther. 2015;13:1357–75.

    Article  CAS  PubMed  Google Scholar 

  5. Lonati C, Morganti A, Italian Society of Hypertension. Clinical management of renovascular hypertension: practical recommendations from the Italian Society of Hypertension (SIIA). High Blood Press Cardiovasc Prev. 2013;20(4):257–60.

    Article  PubMed  Google Scholar 

  6. Wilcox CS. Use of angiotensin-converting-enzyme inhibitors for diagnosing renovascular hypertension. Kidney Int. 1993;44(6):1379–90.

    Article  CAS  PubMed  Google Scholar 

  7. Williams GJ, Macaskill P, Chan SF, et al. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. Am J Roentgenol. 2007;188(3):798–811.

    Article  Google Scholar 

  8. Santos S, Leite LR, Tse TS, Beck R, Lee RA, Shepherd RF. Renal resistance index predicting outcome of renal revascularization for renovascular hypertension. Arq Bras Cardiol. 2010;94(4):452–6.

    Article  PubMed  Google Scholar 

  9. Tafur-Soto JD, White CJ. Renal artery stenosis. Cardiol Clin. 2015;33:59–73.

    Article  PubMed  Google Scholar 

  10. Reiner CS, Goetti R, Eberli D, et al. CT perfusion of renal cell carcionoma: impact of volume coverage on quantitative analysis. Invest Radiol. 2012;47:33–40.

    Article  PubMed  Google Scholar 

  11. Chen Y, Jin Z. Current situation and Prospect of clinical application of the third generation dual source CT. J Chin Acad Med Sci. 2017;39(1):1–3.

    Google Scholar 

  12. AbuRahma AF, Yacoub M. Renal imaging: duplex ultrasound, computed tomography angiography, magnetic resonance angiography, and angiography. Semin Vasc Surg. 2013;26:134–43.

    Article  PubMed  Google Scholar 

  13. De Bruyne B, Manoharan G, Pijls NH, et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol. 2006;48:1851–5.

    Article  PubMed  Google Scholar 

  14. Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763–816.

    Article  PubMed  Google Scholar 

  15. Evans KL, Tuttle KR, Foh DA, et al. Use of reninangiotensin inhibitors in people with renal artery stenosis. Clin J Am Soc Nephrol. 2014;9:1199–206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Cooper CJ, Murphy TP, Cuflip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370:13–22.

    Article  CAS  PubMed  Google Scholar 

  17. Parikh SA, Shishehbor MH, Gray BH, et al. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv. 2014;84:1163–71.

    Article  PubMed  Google Scholar 

  18. Anderson JL, Halperin JL, Albert NM, et al. Management of patients with peripheral artery disease (compilation of 2005 and 201 1 ACCF/AHA guideline recommendations):a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2013;127:1425–43.

    Article  PubMed  Google Scholar 

  19. Wheatley K, Ives N, et al. Revaseularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953–62.

    Article  PubMed  Google Scholar 

  20. Karetová D, Hirmerová J, Matuška J. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Cor Vasa. 2018:S0010865017302035.

    Google Scholar 

  21. Peng M, Jiang XJ, Dong H, et al. Etiology of renal artery stenosis in 2047 patients: a single-center retrospective analysis during a 15-year period in China. Chin Circ J. 2015;30(s1):124.

    Google Scholar 

  22. Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: a population-based study[J]. J Vasc Surg. 2002;36(3):443–51.

    Article  PubMed  Google Scholar 

  23. Sigvant B, Lundin F, Wahlberg E. The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2016;51(3):395–403.

    Article  CAS  PubMed  Google Scholar 

  24. Textor SC, Lerman L. Renovascular hypertension and ischemic nephropathy. Comprehens Clin Nephrol. 2010;23(11):451–68.

    Article  Google Scholar 

  25. Chrysochou C, Kalra PA. Epidemiology and natural history of atherosclerotic renovascular disease. Prog Cardiovasc Dis. 2009;52:184–95.

    Article  PubMed  Google Scholar 

  26. Bookstein JJ, Abrams HL, Buenger RE, et al. Radiologic aspects of renovascular hypertension. JAMA. 1972;220:1218–24.

    Article  CAS  PubMed  Google Scholar 

  27. Lim S, Vos T, Bruce N. The burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions 1990-2010: a systematic analysis. Lancet. 2012;380(9859):2224–60.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kardiologicznego GRET, Rydén L, Grant PJ, et al. ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD. Kardiol Pol. 2013;71(Suppl 11(XI)):S319.

    Google Scholar 

  29. Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2013;370(1):13–22.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Khosla S, Ahmed A, Siddiqui M, et al. Safety of angiotensin-converting enzyme inhibitors in patients with bilateral renal artery stenosis following successful renal artery stent revascularization. Am J Ther. 2006;13(4):306–8.

    Article  PubMed  Google Scholar 

  31. Evans KL, Tuttle KR, Folt DA, et al. Use of renin-angiotensin inhibitors in people with renal artery stenosis. Clin J Am Soc Nephrol. 2014;9(7):1199–206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Foy A, Ruggiero NJI, Filippone EJ. Revascularization in renal artery stenosis. Cardiol Rev. 2012;20(4):189–93.

    Article  PubMed  Google Scholar 

  33. Tan J, Filobbos R, Raghunathan G, et al. Efficacy of renal artery angioplasty and stenting in a solitary functioning kidney. Nephrol Dial Transplant. 2007;22(7):1916–9.

    Article  PubMed  Google Scholar 

  34. Jiang X, Peng M, Li B, et al. The efficacy of renal artery stent combined with optimal medical therapy in patients with severe atherosclerotic renal artery stenosis. Curr Med Res Opin. 2016;32(sup2):3–7.

    Article  PubMed  Google Scholar 

  35. Martin LG, Rundback JH, Wallace MJ, et al. Quality improvement guidelines for angiography, angioplasty, and stent placement for the diagnosis and treatment of renal artery stenosis in adults. J Vasc Interv Radiol. 2010;21(4):421–30.

    Article  PubMed  Google Scholar 

  36. Rooke TW, Hirsch AT, Misra S, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations). J Am Coll Cardiol. 2013;61(14):1555–70.

    Article  PubMed  Google Scholar 

  37. Zahringer M, Sapoval M, Pattynama PMT, et al. Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT trial): angiographic follow-up after 6 months and clinical outcome up to 2 years. J Endovasc Ther. 2007;14(4):460–8.

    Article  PubMed  Google Scholar 

  38. Takahashi EA, Mckusick MA, Bjarnason H, et al. Treatment of in-stent restenosis in patients with renal artery stenosis. J Vasc Interv Radiol. 2016;27:1657–62.

    Article  PubMed  Google Scholar 

  39. Zähringer M, Pattynama PMT, Talen A, et al. Drug-eluting stents in renal artery stenosis. Eur Radiol. 2008;18:678–82.

    Article  PubMed  Google Scholar 

  40. Diop AN, Hoang VV, Cassagnes L, et al. Treatment of atheromatous renal artery in-stent restenosis in 51 patients. Diagn Interv Imaging. 2013;94:68–77.

    Article  Google Scholar 

  41. Itani HS, Mudawwar WA, Tanios BY, et al. First use of a drug-eluting balloon in the treatment of acute renal artery occlusion and in-stent restenosis. Am J Med Sci. 2013;346:244–6.

    Article  PubMed  Google Scholar 

  42. Silverman SH, Exline JB, Silverman LN, et al. Endovascular brachytherapy for renal artery in-stent restenosis. J Vasc Surg. 2014;60(6):1599–604.

    Article  PubMed  Google Scholar 

  43. https://www.ncbi.nlm.nih.gov/mesh/?term=fibromuscular+dysplasia. MeSH Unique ID: D005352.

  44. Persu A, Giavarini A, Touzé E, et al. ESH Working Group Hypertension and the Kidney. European consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens. 2014;32(7):1367–78. PMID: 24842696.

    Article  CAS  PubMed  Google Scholar 

  45. Plouin PF, Perdu J, La Batide-Alanore A, et al. Fibromuscular dysplasia. Orphanet J Rare Dis. 2007;2:28. Review. PubMed PMID: 17555581.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Olin JW, Froehlich J, Gu X, et al. The United States registry for fibromuscular dysplasia: results in the first 447 patients. Circulation. 2012;125(25):3182–90. PubMed PMID: 22615343.

    Article  PubMed  Google Scholar 

  47. Savard S, Azarine A, Jeunemaitre X, et al. Association of smoking with phenotype at diagnosis and vascular interventions in patients with renal artery fibromuscular dysplasia. Hypertension. 2013;61(6):1227–32. PubMed PMID: 23608656.

    Article  CAS  PubMed  Google Scholar 

  48. Harrison EG Jr, McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc. 1971;46(3):161–7. PubMed PMID: 5553126.

    PubMed  Google Scholar 

  49. Kincaid OW, Davis GD, Hallermann FJ, Hunt JC. Fibromuscular dysplasia of the renal arteries. Arteriographic features, classification, and observations on natural history of the disease. Am J Roentgenol Radium Ther Nucl Med. 1968;104(2):271–82. PubMed PMID: 5685786.

    Article  CAS  PubMed  Google Scholar 

  50. Olin JW, Gornik HL, Bacharach JM, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014;129(9):1048–78. PubMed PMID: 24548843.

    Article  PubMed  Google Scholar 

  51. Savard S, Steichen O, Azarine A, et al. Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics. Circulation. 2012;126(25):3062–9. PubMed PMID: 23155180.

    Article  PubMed  Google Scholar 

  52. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Trans Atlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463–654. PMID: 16549646.

    Article  PubMed  Google Scholar 

  53. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141(9):674–82. PMID: 15520423.

    Article  PubMed  Google Scholar 

  54. Gaddikeri S, Mitsumori L, Vaidya S, et al. Comparing the diagnostic accuracy of contrast-enhanced computed tomographic angiography and gadolinium-enhanced magnetic resonance angiography for the assessment of hemodynamically significant transplant renal artery stenosis. Curr Probl Diagn Radiol. 2014;43(4):162–8. PMID: 24948209.

    Article  PubMed  Google Scholar 

  55. Fournier T, Sens F, Rouvière O, et al. Management of atherosclerotic renal-artery stenosis in 2016. Nephrol Ther. 2017;13(1):1–8. PMID: 27887845.

    Article  PubMed  Google Scholar 

  56. Jiang X, Zou Y. Chinese expert consensus on diagnosis and treatment of renal artery stenosis. Chin J Circ. 2017;32(9):835–44.

    Google Scholar 

  57. Kalra PA, Guo H, Gilbertson DT, et al. Atherosclerotic renovascular disease in the United States. Kidney Int. 2010;77(1):37–43. PMID: 19865075.

    Article  CAS  PubMed  Google Scholar 

  58. Alexander A, Richmond L, Geary D, et al. Outcomes of percutaneous transluminal angioplasty for pediatric renovascular hypertension. J Pediatr Surg. 2017;52(3):395–9. PMID: 27634559.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Center of Hypertension of People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China

    Mengru Wang, Jina Yili, Keming Zhou, Guoliang Wang & Bin Zhu

Authors
  1. Mengru Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jina Yili
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Keming Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guoliang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bin Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Center of Hypertension of People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China

    Nanfang Li

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wang, M., Yili, J., Zhou, K., Wang, G., Zhu, B. (2020). Renovascular Hypertension. In: Li, N. (eds) Secondary Hypertension. Springer, Singapore. https://doi.org/10.1007/978-981-15-0591-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-0591-1_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-0590-4

  • Online ISBN: 978-981-15-0591-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation